Erica K Barnell

Publications

title citation publication date
A Phase II trial of neoadjuvant MK2206, an AKT inhibitor, with anastrozole in clinical stage 2 or 3 PIK3CA mutant ER positive and HER2 negative breast cancer Clin Cancer Res. 2017 Sep 5. pii: clincanres.1260.2017. doi: 10.1158/1078-0432.CCR-17-1260. [Epub ahead of print] 1970-08-22
CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer Nat Genet. 2017 Jan 31;49(2):170-174. doi: 10.1038/ng.3774. 2017-01-31
CIViC: A knowledgebase for expert-crowdsourcing the clinical interpretation of variants in cancer doi: http://dx.doi.org/10.1101/072892